National Institute of Diabetes and Digestive and Kidney Diseases | Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R; Thielecke; Abel; Bergemann 2006 |
---|---|
"The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis" | "The burden of illness of irritable bowel syndrome: current challenges and hope for the future" |
Epidemiology, pathogenesis, and diagnosis of inflammatory bowel diseases.
In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management | |
---|---|
In: Nelson Textbook of Pediatrics | Spiller R, Garsed K; Garsed May 2009 |
Antibiotics and probiotics in inflammatory bowel disease: When to use them? The American journal of gastroenterology.
29"Costs of irritable bowel syndrome in the UK and US" | San Diego, Calif: Academic Press |
---|---|
Xeljanz, Xeljanz XR tofacitinib : Drug safety communication — Initial safety trial results find increased risk of serious heart-related problems and cancer with arthritis and ulcerative colitis medicine |
.